Tb-161 is a therapeutic isotope that emits both beta particles and a significant number of short-range Auger electrons. This combination allows it to damage tumor cells efficiently, especially at close range, while reducing harm to healthy tissue. When paired with cancer-targeting molecules, Tb-161 can deliver highly localized radiation to tumors and is being explored as a next-generation option in radionuclide therapy.
Tb-161 Terbium
Please note that your order date is important due to production, calibration and shipment days.